Introduction {#Sec1}
============

The production of fuels from renewable materials has received increased attention due to the limited supply of fossil fuels and increasing environmental concerns. The annual production of ethanol in the USA reached 9.2 billion gallons in 2008 (Seiferlein [@CR31]). Although ethanol production by fermentation has a long history and plays an important role for transition to bio-based fuels, it is not an ideal gasoline replacement due to its low energy density (∼70% of gasoline), high vapor pressure, and high hygroscopicity, making ethanol incompatible with the current infrastructure. In contrast, higher chain alcohols possess elevated energy densities and are compatible with the existing infrastructure. 1-Butanol production by fermentation was first accomplished with *Clostridium acetobutylicum* as a host about a century ago and has recently received significant attention (Borden and Papoutsakis [@CR10]; Ezeji et al. [@CR18]). In the past few years, the production of this alcohol and several other higher chain alcohols such as 1-propanol, isobutanol, 2-methyl-1-butanol, and 3-methyl-1-butanol have been demonstrated in *Escherichia coli* (Atsumi et al. [@CR3], [@CR4]; Atsumi and Liao [@CR2]; Cann and Liao [@CR12]; Connor and Liao [@CR13]; Shen and Liao [@CR32]). Isobutyraldehyde and isobutanol production by photosynthetic CO~2~ recycling has also been accomplished in *Synechococcus elongatus* (Atsumi et al. [@CR6]).

*Corynebacterium glutamicum* is a rapidly growing, gram-positive soil bacterium and has been the workhorse of industrial amino acid production (Leuchtenberger et al. [@CR22]). The discovery of this organism's ability to produce glutamate with high efficiency led to the development of amino acid production by fermentation. In 2005, *C. glutamicum* was used to produce 1.5 million tons of glutamate as monosodium glutamate per year as well as several thousand tons of other amino acids such as lysine, isoleucine, tryptophan, and threonine. These processes have been engineered extensively, with valine and lysine production titers reaching ∼100 g/L (Leuchtenberger et al. [@CR22]). Because these 2-keto acid pathways for higher chain alcohol production share common precursors with amino acids, *C. glutamicum* shows potential for the production of higher chain alcohols. To our knowledge, this organism has never been used to synthesize any alcohols beyond ethanol (Inui et al. [@CR20]).

Valine, which shares the 2-keto acid precursor, 2-ketoisovalerate (KIV), with isobutanol, has been produced in *C. glutamicum* from glucose by overexpression of the valine biosynthesis pathway (*ilvBNCDE*) and elimination of carbon competing pathways (Blombach et al. [@CR9]; Radmacher et al. [@CR29]). To produce isobutanol in *C. glutamicum*, we applied a similar strategy by overexpression of the 2-keto acid synthesis pathway (Fig. [1](#Fig1){ref-type="fig"}). This pathway includes *alsS* (*Bacillus subtilis*) and *ilvCD* (*C. glutamicum*) along with downstream genes for the subsequent decarboxylation (*kivd* from *L. lactis*) and reduction (*adhA* from *C. glutamicum*) of 2-ketoisovalerate to isobutanol. Fig. 12-Keto acid based higher alcohol production pathways from glucose in *C. glutamicum*. *KIV* 2-ketoisovalerate, *KIC* 2-ketoisocaproate, *KV* 2-ketovalerate, *KB* 2-ketobutyrate, *KMV* 2-keto-3-methyl-valerate, *PEP* phosphoenolpyruvate, *OAA* oxaloacetate

Materials and methods {#Sec2}
=====================

Reagents {#Sec3}
--------

All restriction enzymes and antarctic phosphatase were purchased from New England Biolabs (Ipswich, MA, USA). The DNA ligation kit was supplied by Roche (Manheim, Germany). KOD DNA polymerase was purchased from EMD Chemicals (San Diego, CA, USA). Oligonucleotides were ordered from Integrated DNA Technologies (Coralville, IA, USA).

Strains and plasmids {#Sec4}
--------------------

All strains, plasmids, and oligonucleotides used are listed in Table [1](#Tab1){ref-type="table"}. *E. coli* XL1-Blue (Stratagene) was used to propagate all plasmids. All corynebacteria strains used were derived from *C. glutamicum* ATCC 13032, which was used as wild type (WT). Gene knockout in *C. glutamicum* was achieved using pK19mobsacB as previously described (Schäfer et al. [@CR30]). To begin construction of the isobutanol production plasmid, a multiple cloning site and a transcriptional terminator from the *ilvBNC* operon of *C. glutamicum* was made by primer elongation using oligonucleotides (K673--K676). The PCR product was digested with *Mfe*I and *Pst*I and ligated into pEP2 digested with *Eco*RI and *Pst*I to obtain pKS122. The *cat* (encoding chloramphenicol acetyltransferase) gene was cloned from pZA31 (Lutz and Bujard [@CR24]) with primers K709 and K710, digested with *Sal*I and *Not*I, and ligated into pKS122 cut with the same enzymes to obtain pKS133. The *eftu* promoter, which transcribes the *eftu* gene (Cg0587), was amplified from genomic DNA (ATCC 13032) with primers K717 and K718, digested with *Pst*I and *Sal*I, and ligated into pKS133 cut with the same restriction enzymes to obtain pKS140. To clone *alsS* of *B. subtilis*, the gene was amplified from pSA69 (Atsumi et al. [@CR4]) with primers K753 and A124, digested with *Xho*I and *Sal*I, and ligated into pKS140 cut with *Sal*I to obtain pKS149. *IlvC* and *ilvD* of *C. glutamicum* were amplified by PCR from genomic DNA (ATCC 13032) with primers K764 and K765 and K766 and K767, respectively. The PCR products were fused together by sequential overlap extension, digested with *Xho*I and *Not*I, and ligated into pKS149 cut with *Sal*I and *Not*I to give pKS152. pKS154 was constructed by amplifying *kivd* of *L. lactis* from pSA55 (Atsumi et al. [@CR4]) with K852 and K853, digesting the PCR product with *Not*I and *Spe*I and ligating into pKS152 cut with the same restriction enzymes. *adhA (*Cg3107) of *C. glutamicum* was amplified from genomic DNA using primers K887 and K888, and the PCR product was digested with *Spe*I and ligated into pKS154 cut with the same enzyme to obtain pKS167. For construction of pKS160, the *eftu* promoter was amplified with primers K717 and K718, digested with *Pst*I and *Sal*I, and ligated into pKS122 cut with the same enzymes. Inactivation of chromosomal genes was done as previously described (Schäfer et al. [@CR30]). Plasmid p∆*pyc* was constructed using primers K976 + K977 and K978 + K979 to amplify the terminal regions of *pyc* from genomic DNA for construction of the *pyc* fragment. Likewise, plasmid p∆*ppc* was constructed using K972 + K973 and K974 + K975, plasmid p∆*aceE* was constructed using K960 + K961 and K962 + K963, and plasmid p∆*pgi* with primers K950 + K951 and K952 + K953 and plasmid p∆*ilvE* was constructed using K21 + K22 and K23 + K24. The two PCR products were fused together by sequential overlap extension, digested with *Mfe*I and *Hin*dIII (*pyc*, *aceE*, and *pgi* fragments) or with *Hin*dIII and *Eco*RI (*ppc* and *ilvE* fragments), and ligated into pK19mobsacB cut with *Eco*RI and *Hin*dIII. All knockouts were confirmed by PCR (Table [2](#Tab2){ref-type="table"}). Table 1Strains and plasmids used in this studyNameRelevant genotypeReferenceStrains*E. coli* BW25113*rrnB*~T14~ D*lacZ*WJ16 *hsdR514* D*araBAD*~AH33~ D*rhaBAD*~LD78~(Datsenko and Wanner [@CR14])*E. coli* XL-1 Blue*recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac* \[F´ *proAB lacI*^*q*^*Z*∆*M15 Tn10* (Tet^R^)\]Stratagene*C. glutamicum* ATCC 13032Wild type (WT)American Type Culture Collection∆*aceE*∆*aceE* (Cg2466)This study∆*ilvE*∆*ilvE* (Cg2418)This study∆*ppc*∆*ppc* (Cg1787)This study∆*pyc*∆*pyc* (Cg0791)This study∆*aceE*∆*ldh*∆*aceE*∆*ldh* (Cg3219)This study∆*aceE*∆*ldh*∆*pgi*∆*aceE*∆*ldh*∆*pgi* (Cg0973)This studyPlasmidspK19mobsacBKan^R^; mobilizable (oriT, oriV); sacB; lacZα(Schäfer et al. [@CR30])pZA31P15A ori; Cm^R^; P~L~tetO~1~::*luc*(Lutz and Bujard [@CR24])pSA55ColE1 ori; Amp^R^; P~L~lacO~1~::*kivd-ADH2*(Atsumi et al. [@CR4])pSA69p15A ori; Kan^R^; P~L~lacO~1~::*alsS-ilvC-ilvD*(Atsumi et al. [@CR4])pEP2NG2 ori; Kan^R^(Messerotti et al. [@CR28])pKS122NG2 ori; Kan^R^; MCSThis studypKS133NG2 ori; Kan^R^; *cat*This studypKS140NG2 ori; Kan^R^; P~*eftu*~::*cat*This studypKS149NG2 ori; Kan^R^; P~*eftu*~::*alsS*This studypKS152NG2 ori; Kan^R^; P~*eftu*~::*alsS-ilvCD*This studypKS154NG2 ori; Kan^R^; P~*eftu*~::*alsS-ilvCD-kivd*This studypKS160NG2 ori; Kan^R^; P~*eftu*~::This studypKS167NG2 ori; Kan^R^; P~*eftu*~::*alsS-ilvCD-kivd-adhA*This studyp∆*aceE*As pK19mobsacB but with *aceE* fragmentThis studyp∆*ilvE*As pK19mobsacB but with *ilvE* fragmentThis studyp∆*ldh*As pK19mobsacB but with *ldh* fragmentThis studyp∆*pgi*As pK19mobsacB but with *pgi* fragmentThis studyp∆*ppc*As pK19mobsacB but with *ppc* fragmentThis studyp∆*pyc*As pK19mobsacB but with *pyc* fragmentThis studyTable 2Oligonucleotides used in this studyPrimer nameSequence 5′→3′K21GGCG[AAGCTT]{.ul}GTGGCATCCTTGGACACCTTGK22CTTGATGGTTTCGTCCGAATGGCK23CATTCGGACGAAACCATCAAGGGCTAAATCAACCGGTTTTAAGACCCK24GG[GAATTC]{.ul}TTCCGTGGCAACTCGACCTGK673GCA[CAATTG]{.ul}CGTCAAAGGGGTGAAACTTAAGCAATTCK674GATTTTGGCAAAATGGTGGAAGGGCGGATCCTGCTAGCAGCCACTAK675GGATCCTGCTAGCAGCCACTAGTTAGCTCTAGAAATAGCATGCCAGCAGATCTAAK676AAGC[CTGCAG]{.ul}GTCGACAAGCGGCCGCAATCCTAGGTTTAGATCTGCTGGCATGCTATTTK709GG[GTCGAC]{.ul}ATGGAGAAAAAAATCACTGGATATACCACCK710GGCG[GCGGCCGC]{.ul}TTACGCCCCGCCCTGCCACTK717AA[CTGCAG]{.ul}GGTGACGTGAACTCCCGCCGK718GG[GTCGAC]{.ul}TGTATGTCCTCCTGGACTTCGTGGK753GGCCG[CTCGAG]{.ul}ATGTTGACAAAAGCAACAAAAGAACAAAAATA124ACGCA[GTCGAC]{.ul}CTAGAGAGCTTTCGTTTTCATGAGTK764GGCCG[CTCGAG]{.ul}ATTAAAGAGGAGAAAGGTAATGGCTATTGAACTGCTTTATGATGCTGK765CATTACCTTTCTCCTCTTTAATTTAAGCGGTTTCTGCGCGAGCK766ATTAAAGAGGAGAAAGGTAATGATCCCACTTCGTTCAAAAGTCACK767GGCG[GCGGCCGC]{.ul}TTAGTCGACCTGACGGACTGCACCK852GGCG[GCGGCCGC]{.ul}AAAGAGGAGAAAGGTACCATGTATACAGTAGGAGK853GG[ACTAGT]{.ul}TTATGATTTATTTTGTTCAGCAAATAGTTTGCK887GG[ACTAGT]{.ul}GAAGTCCAGGAGGGCTGCAATGACCACTGCTGCACCCCAAGK888GG[ACTAGT]{.ul}TTAGAAACGAATCGCCACACGACCK950GGCG[AAGCTT]{.ul}CCTACGAAGAAGGCGGAGAAACTK951GCGCGGTTTTCTTCCTTGAAAAGTK952ACTTTTCAAGGAAGAAAACCGCGCGGCAAATGACCTCGCTCCGGK953GG[GAATTC]{.ul}GACGCGGAAAATACTCCCTAACAGCK960GGCG[AAGCTT]{.ul}ATGGCCGATCAAGCAAAACTTGGK961CCATGAATGCACGTGCGTACATK962GTACGCACGTGCATTCATGGATCGCACACCTGGTTCACCGK963GCA[CAATTG]{.ul}TTATTCCTCAGGAGCGTTTGGATCTK972GGCG[AAGCTT]{.ul}ATGACTGATTTTTTACGCGATGACATCAGK973CTCCGCAGACTGCAAAGCGTK974ACGCTTTGCAGTCTGCGGAGGGGTGCTCAGCTGGTCACAGK975GG[GAATTC]{.ul}CTAGCCGGAGTTGCGCAGCK976GGCG[AAGCTT]{.ul}GTGTCGACTCACACATCTTCAACGK977CTTCACAAAGATGGGGTAAGTCTGGCK978ACTTACCCCATCTTTGTGAAGCGCTTCGGCAACACCTCTGK979GCA[CAATTG]{.ul}TTAGGAAACGACGACGATCAAGTCGUnderlined nucleotides indicate restriction sites

Medium and cultivation {#Sec5}
----------------------

*E. coli* cultures for plasmid construction and propagation were grown in Luria--Bertani (LB) media at 37°C and shaken at 250 rpm. For stepwise construction of the isobutanol pathway, the cultures were grown in 20-mL media CGIII (Menkel et al. [@CR27]), but with 40 g/L glucose in a 250-mL screw-cap shake flask. Longer-term production cultures were done in 20 mL CGIII media but with 70 g/L glucose in a 250-mL screw-cap flask. All strains with an *aceE* knockout were cultured in the same production media but with 4.5 g/L acetate to allow for adequate cell growth. All *C. glutamicum* production cultures were inoculated to an initial OD~600\ nm~ of 0.1 from a 3-mL overnight culture grown in CGIII at 30°C in a rotary shaker (250 rpm). After inoculation, production cultures were shaken at 250 rpm and 30°C. The pH values of long-term production cultures were checked at every sampling time, and 10 M NaOH was added as needed to adjust to pH 6.8. Antibiotics were added appropriately (kanamycin 25 μg/mL).

Tolerance assays {#Sec6}
----------------

Cultures of *E. coli* BW25113 were grown at 30°C and 37°C in LB with 2% glucose (LBG) in a 500-mL baffled shake flask at 250 rpm. *C. glutamicum* was grown in LBG and CGIII media at 30°C in a 500-mL baffled shake flask at 250 rpm. After an OD of 1.0 was reached, 5-mL aliquots were moved into test tubes, isobutanol was added at varied concentrations (0%, 1.0%, 1.25%, 1.5%, 1.75%, and 2.0%), and the cultures were incubated at 30°C and shaken at 250 rpm. After 4 h, each culture was diluted and spread onto LB plates for colony counting after 24 h of incubation at 30°C. Percent viability was calculated as the number of cells remaining viable after isobutanol exposure normalized with the cell number obtained with no isobutanol exposure.

Enzymatic assays {#Sec7}
----------------

For crude extract enzyme assays, 5-mL CGIII cultures of *C. glutamicum* harboring the relevant plasmids were grown overnight at 30°C in 5 mL CGIII media in test tubes. Crude extracts were prepared by concentrating the cultures by 5-fold in 0.1 M phosphate buffer (pH 7.1) and lysing them with 0.1 mM glass beads. The acetolactate synthase (ALS) assay was performed as previously reported (Holtzclaw and Chapman [@CR19]). KDC activity was assayed by measuring the generation of isobutyraldehyde from 2-ketoisovalerate as previously described (Atsumi et al. [@CR5]). Reductive ADH activity was detected by measuring NADH oxidation at 340 nm in 1 mL of 50 mM phosphate buffer (pH 7.1), 100 mM isobutyraldehyde, 250 μM NADH, and 100 μL crude extract. Oxidative ADH activity was detected by measuring NAD^+^ reduction at 340 nm in 1 mL of 50 mM phosphate buffer (pH 7.1), 500 mM ethanol or isobutanol, 250 μM NAD^+^, and 100 μL crude extract. Total protein concentrations were measured by Bradford assay.

Metabolite detection {#Sec8}
--------------------

The alcohol compounds produced were quantified using gas chromatography equipped with flame ionization as previously described (Atsumi et al. [@CR3]). All other compounds were measured by applying filtered fermentation broth to an Agilent 1100 high-performance liquid chromatograph equipped with an autosampler (Agilent Technologies) and a Bio-Rad Aminex HPX87 column (5 mM H~2~SO~4~; 0.3 mL/min; column temperature, 35°C; Bio-Rad Laboratories, Hercules, CA, USA).

Results {#Sec9}
=======

*C. glutamicum* exhibits better isobutanol tolerance than *E. coli* {#Sec10}
-------------------------------------------------------------------

The capability of *C. glutamicum* to tolerate isobutanol toxicity was evaluated by exposing the organism to isobutanol at different concentrations and determining the percentage of cells that remained viable relative to no alcohol exposure. In addition to *C. glutamicum*, we also performed the same experiment with *E. coli*, which is a successful isobutanol-producing organism (Atsumi et al. [@CR4]). Initially, both organisms were cultured in LB with 2% glucose (LBG) at 30°C to compare their tolerance levels in identical growth conditions (Fig. [2a](#Fig2){ref-type="fig"}). However, because LBG is not an optimal growth medium for *C. glutamicum*, the isobutanol tolerance of this organism was assayed in CGIII medium as well (Fig. [2b](#Fig2){ref-type="fig"}). Likewise, we investigated the ability of *E. coli* to tolerate isobutanol toxicity at its optimal growth temperature, 37°C (Fig. [2b](#Fig2){ref-type="fig"}). We found that *C. glutamicum* is more tolerant of isobutanol toxicity than *E. coli* for all concentrations and conditions tested (Fig. [2](#Fig2){ref-type="fig"}). No significant difference in the viability of *E. coli* at 30°C or 37°C was found; however, the viability of *C. glutamicum* was improved in CGIII media in comparison with LBG media at 10 and 12.5 g/L isobutanol. In LBG media with 10 g/L isobutanol, 51% of *C. glutamicum* cells remained viable after exposure, whereas 30% and 24% of *E. coli* cells remained viable when incubated at 30°C and 37°C, respectively. For all concentrations at or below 12.5 g/L isobutanol in both mediums tested, *C. glutamicum* displayed 2-fold better viability in comparison with *E. coli*. At 20 g/L isobutanol, *C. glutamicum* showed 18% cell viability in LBG, which is 4-fold higher than the 4% cell viability obtained with *E. coli* incubated at 37°C. This beneficial characteristic of *C. glutamicum* further increased our motivation to pursue higher chain alcohol production with this host. Fig. 2Comparison of isobutanol tolerance of *C. glutamicum* and *E. coli* by exposure to isobutanol and calculation of% viable cells remaining. **a***E. coli* and *C. glutamicum* cultured in LBG medium at 30°C, **b***E. coli* and *C. glutamicum* cultured in LBG medium at 37°C and CGIII medium at 30°C, respectively. Data shown are the result of three independent experiments

Constructing the isobutanol production pathway {#Sec11}
----------------------------------------------

We aimed to produce isobutanol as a primary fermentation product from glucose using *C. glutamicum*. First, a plasmid for expression of the isobutanol pathway was constructed. The promoter of *eftu* (P~*eftu*~), encoding elongation factor TU, was chosen for transcription of the entire isobutanol operon. Second, we selected ALS (acetolactate synthase) of *B. subtilis* (Holtzclaw and Chapman [@CR19]) to catalyze the first reaction from pyruvate. To ensure that both P~*eftu*~ and ALS have functional activity in *C. glutamicum*, crude extract ALS enzyme assays (Holtzclaw and Chapman [@CR19]) were performed. The activity of the heterologous ALS in wild-type *C. glutamicum* was found to be 6,700 U mg^−1^, whereas an activity of 100 U mg^−1^ was detected with no ALS expression (Table [3](#Tab3){ref-type="table"}), confirming that ALS and the P~*eftu*~ have good activity in *C. glutamicum.* Following ALS, the native enzymes, IlvC and IlvD, were overexpressed to convert the 2-acetolactate produced from pyruvate by ALS to 2-ketoisovalerate. The promiscuous KDC of *L. lactis*, encoded by *kivd*, was employed to decarboxylate KIV to isobutyraldehyde, which is then reduced by an alcohol dehydrogenase to produce isobutanol (Fig. [1](#Fig1){ref-type="fig"}). Because expression of KDC in *C. glutamicum* has never been accomplished, crude extract enzyme assays were performed to confirm it has activity for KIV in this host. Indeed, we verified the activity of KDC to be 2.3 ± 0.6 U mg^−1^ from *C. glutamicum* harboring pKS167, whereas no KDC activity was detected with an empty plasmid (pKS160). For our initial attempt at isobutanol production, we selected *adhA*, a native alcohol dehydrogenase previously identified to be NADH specific (Arndt and Eikmanns [@CR1]) and determined its activity for isobutyraldehyde reduction to be 0.62 ± 0.06 U mg^−1^, whereas an activity of 0.09 U mg^−1^ was detected with no *adhA* overexpression (Table [3](#Tab3){ref-type="table"}). In *C. glutamicum*, *adhA* has been demonstrated to be required for growth on ethanol, generating acetaldehyde and NADH (Arndt and Eikmanns [@CR1]); however, we did not detect any oxidative activity with isobutanol as substrate with this enzyme. Table 3Specific activities of ALS, KDC, and *adhA* obtained by overexpression in *C. glutamicum* using P~*eftu*~PlasmidOverexpressionSubstrateCofactorSpecific activity (U mg^−1^)pKS149*alsS*Pyruvate--6,700 ± 600pKS160--Pyruvate--110 ± 9pKS167*kivd*2-Ketoisovalerate--2.3 ± 0.6pKS160--2-Ketoisovalerate--NDpKS167*adhA*IsobutyraldehydeNADH0.62 ± 0.06pKS160--IsobutyraldehydeNADH0.09 ± 0.02For ALS activity, one unit equals 1 nmol of 2-acetolacate produced per minute. For KDC activity, one unit equals the formation of 1 μmol of isobutyraldehyde per minute at standard conditions (pH 7.0, 37°C). For ADH activity, one unit equals 1 μmol of NADH oxidized per minute. Data shown are the averages of three independent experiments*U* unit, *ND* not detected

Isobutanol production with *C. glutamicum* {#Sec12}
------------------------------------------

The effects of overexpression of the three steps from pyruvate to KIV (*alsS-ilvCD*) followed by sequential overexpression of *kivd* and a native alcohol dehydrogenase, encoded by *adhA*, on isobutanol production were determined (Fig. [3](#Fig3){ref-type="fig"}). Overexpression of *alsS-ilvCD* without *kivd* did not produce any isobutanol, demonstrating that *C. glutamicum* does not have an endogenous KDC with activity toward KIV. The added overexpression of *kivd* resulted in the production of 2.2 g/L isobutanol in 48 h (Fig. [3](#Fig3){ref-type="fig"}) and, in addition, 0.4 g/L of 3-methyl-1-butanol (Table [4](#Tab4){ref-type="table"}), confirming that one or more of the five putative and confirmed ADHs of *C. glutamicum* (Arndt and Eikmanns [@CR1]) are capable of reducing isobutyraldehyde to isobutanol. Isobutyraldehyde was detected (350 mg/L), indicating the need for overexpression of an alcohol dehydrogenase. By overexpression of *adhA*, the final isobutanol titer was increased to 2.6 g/L, and isobutyraldehyde accumulation was reduced to 50 mg/L (Fig. [3](#Fig3){ref-type="fig"}). Also, 1-propanol, 1-butanol, 2-methyl-1-butanol, and 2-phenylethanol were detected as byproducts (Table [4](#Tab4){ref-type="table"}), demonstrating this organism's ability to produce several higher alcohols. Fig. 3Effects of the systematic overexpression of the synthetic isobutanol pathway on isobutanol production in *C. glutamicum*. Plus symbols denote overexpression of the indicated gene(s) or the addition of 40 g/L glucose to the media. Data obtained are the result of three independent fermentationsTable 4Alcohols produced from glucose by overexpression of different genes of the isobutanol production pathway in *C. glutamicum*Data shown are the average of three independent experiments

Strain improvement by gene knockout {#Sec13}
-----------------------------------

Batch fermentations of *C. glutamicum* harboring pKS167 (P~*eftu*~::*alsS-ilvCD-kivd-adhA*) were performed to characterize long-term isobutanol production in different backgrounds (Fig. [4](#Fig4){ref-type="fig"}). WT produced 4.0 g/L isobutanol in 96 h (Fig. [4a](#Fig4){ref-type="fig"}) and the overall product yield was found to be 0.08 g/g (isobutanol/glucose), which is 19% of the theoretical maximum. HPLC analysis led to the detection of only 0.9 g/L acetate in the fermentation medium (Fig. [4d](#Fig4){ref-type="fig"}). We attempted to increase the isobutanol titer by inactivating several enzymes that may consume precursors of the isobutanol pathway. First, we implemented single knockouts of *ppc* (encoding phosphoenolpyruvate carboxylase), *pyc* (encoding pyruvate carboxylase), and *ilvE* (encoding valine transaminase) to eliminate the consumption of phosphoenolpyruvate, pyruvate, and KIV, respectively. The ∆*ppc* and ∆*ilvE* strains were found to be ineffective at increasing the isobutanol titer and performed as WT (data not shown), and the ∆*pyc* strain slightly improved the isobutanol titer to 4.3 g/L (Fig. [4a](#Fig4){ref-type="fig"}). Furthermore, inactivation of PYC led to the accumulation of 2.6 g/L lactate (Fig. [4c](#Fig4){ref-type="fig"}), whereas acetate production was relatively unaffected (Fig. [4d](#Fig4){ref-type="fig"}). To direct the accumulated lactate in the ∆*pyc* strain toward isobutanol synthesis, we disrupted *ldh* (encoding lactate dehydrogenase (LDH)) and found that it increased the final isobutanol titer by ∼25% to 4.9 g/L isobutanol (Fig. [4a](#Fig4){ref-type="fig"}) as well as increased cell growth (Fig. [4e](#Fig4){ref-type="fig"}). Fig. 4Long-term isobutanol production in *C. glutamicum* harboring pKS167 (P~*eftu*~::*alsS-ilvCD-kivd-adhA*). **a** Isobutanol production, **b** glucose consumption, **c** lactate production, **d** acetate production, and **e** cell growth. WT (*open circles*), ∆*pyc* (*open diamonds*), ∆*pyc*∆*ldh* (*closed circles*), ∆aceE (*open squares*), ∆*aceE*∆*ldh* (*closed squares*), and ∆*aceE*∆*ldh*∆*pgi* (*open triangles*). Data obtained are the result of three independent fermentations

Because we did not detect significant organic acid accumulation in WT, we hypothesized that the pyruvate dehydrogenase complex (PDHc) is a major consumer of pyruvate and constructed a ∆*aceE* strain deficient in PDHc activity. As shown in Fig. [4a](#Fig4){ref-type="fig"}, isobutanol production in the ∆*aceE* background was severely inhibited and only accumulated to 1.4 g/L isobutanol, while cell growth was similar to the other strains tested (Fig. [4e](#Fig4){ref-type="fig"}). Moreover, inactivation of the PDHc resulted in a significant accumulation of 8.3 g/L lactate (Fig. [4c](#Fig4){ref-type="fig"}), indicating that it is the major consumer of pyruvate. Next, we aimed to direct this accumulated lactate through the isobutanol pathway with the additional inactivation of LDH by constructing a ∆*aceE*∆*ldh* strain. The deletion of *ldh* in the ∆*aceE* host did direct the carbon flux away toward isobutanol during the first 24 h. Ultimately, however, this strain did not increase isobutanol production over WT (Fig. [4a](#Fig4){ref-type="fig"}) and the strain excreted 2.1 g/L acetate (Fig. [4d](#Fig4){ref-type="fig"}). This is perhaps due to the activity of pyruvate:quinone oxidoreductase that has been shown to compete for pyruvate to generate acetate (Blombach et al. [@CR9]). At this point, we predicted that isobutanol production in ∆*aceE* strains might be inhibited due to an insufficient supply of NADPH that may be generated from the TCA cycle. To increase NADPH availability, *pgi* (encoding phosphoglucose isomerase, PGI) was knocked out to create a ∆*aceE*∆*ldh*∆*pgi* strain. However, isobutanol production with this strain was eliminated (Fig. [4a](#Fig4){ref-type="fig"}). Also, the glucose consumption rate of the ∆*aceE*∆*ldh*∆*pgi* strain was strongly inhibited (Fig. [4b](#Fig4){ref-type="fig"}), suggesting that PGI is an essential path for glucose metabolism toward isobutanol. Similar to previous studies regarding valine production in *C. glutamicum* (Blombach et al. [@CR9]) and isobutanol production in *E. coli* (Atsumi et al. [@CR4]), we found that all strains produced isobutanol primarily in the stationary phase (Fig. [4e](#Fig4){ref-type="fig"}), and valine was never detected above concentrations present in fresh medium (data not shown).

Discussion {#Sec14}
==========

We engineered *C. glutamicum* for isobutanol production and produced several other higher chain alcohols as byproducts (1-propanol, 1-butanol, 2-methyl-1-butanol, 3-methyl-1-butanol, and 2-phenylethanol), highlighting the capacity of this host for the construction of several different higher chain alcohol production platforms.

Despite the promising use of isobutanol as a fuel, its toxic effects on microbes may be an important factor limiting its production (Brynildsen and Liao [@CR11]). Here, we found that *C. glutamicum* has an increased ability to tolerate isobutanol toxicity in comparison with *E. coli* at all concentrations and conditions tested (0--20 g/L isobutanol), showing that *C. glutamicum* has potential to be a higher alcohol producer as the tolerance of *E. coli* is similar to that of *C. acetobutylicum* (Atsumi et al. [@CR3]; Lin and Blaschek [@CR23]), a natural 1-butanol producer. Corynebacteria possess a thick cell wall that helps protect the cell against external stresses such as freeze damage, pressure, and hyperosmotic shock (Marienfeld et al. [@CR25]). Similar to mycobacteria, the cell wall of corynebacteria contains mycolic acids linked to polysaccharides which, in mycobacteria, form a second bilayer surrounding the cell wall and limiting its permeability (Eggeling and Sahm [@CR16]). The higher isobutanol tolerance of *C. glutamicum* may be the result of these protective characteristics, and this trait may prove to be advantageous for higher chain alcohol production once alcohol titers reach toxic levels.

To begin construction of the isobutanol pathway, the promoter of *eftu* was chosen for expression of the isobutanol operon. This promoter has been shown to be effective for strong gene expression in *C. glutamicum* for the production of lysine (Becker et al. [@CR7]). With this promoter, we were able to successfully express ALS of *B. subtilis* and KDC of *L. lactis* in *C. glutamicum* and obtain good activities*. C. glutamicum* also possesses native acetohydroxyacid synthase (AHAS) enzymes capable of generating 2-acetolactate, one of which has been used for valine production (Radmacher et al. [@CR29]); however, ALS has been shown to be beneficial for isobutanol production in *E. coli*, and, unlike AHAS (encoded by *ilvBN*), ALS is not feedback-inhibited by valine (Elisakova et al. [@CR17]; Holtzclaw and Chapman [@CR19]), and it is more specific for acetolactate synthase activity.

Overexpression of *alsS-ilvCD* without *kivd* did not produce any isobutanol, indicating that *C. glutamicum* does not have an endogenous KDC with activity toward KIV. The additional overexpression of *kivd* and *adhA* resulted in improved production of isobutanol, and we also detected 1-propanol, 1-butanol, 2-phenylethanol, 2-methyl-1-butanol, and 3-methyl-1-butanol as byproducts. We therefore conclude that the overexpessed KDC is active in *C. glutamicum* and that this organism may be engineered to produce a wide array of higher alcohols.

Long-term fermentations with WT harboring pKS167 (P~*eftu*~::*alsS-ilvCD-kivd-adhA*) produced 4.0 g/L isobutanol in 96 h and gave a yield that is 19% of the theoretical maximum (isobutanol/glucose). WT produced isobutanol slowly for the first 24 h when the cells are growing, whereas 85% of the isobutanol was produced after the cells reach stationary phase. In an effort to improve isobutanol productivity, we targeted pathways that were potentially consuming several isobutanol precursors: phosphoenolpyruvate, pyruvate, and KIV. The inactivations of PPC and IlvE did not increase isobutanol production, and disruption of PYC only slightly improved the final titer. However, the absence of PYC resulted in the accumulation of 2.6 g/L lactic acid, indicating that PYC actively consumes pyruvate, which might explain why WT does not produce lactate. Our results also indicate that the pyruvate made available in the ∆*pyc* strain is more effectively consumed by LDH, outcompeting ALS of the isobutanol pathway. This is plausible, as the *K*~m~ value of ALS for pyruvate is 13.6 mM (Atsumi et al. [@CR5]), whereas LDH has a lower *K*~m~ of 7.4 mM (Dietrich et al. [@CR15]), which may explain the increased efficacy of LDH for pyruvate consumption. Our results are in agreement with this argument, as the additional inactivation of the competitive LDH (∆*pyc*∆*ldh*) improved isobutanol production by ∼25% to 4.9 g/L isobutanol and increased the yield to 23% of the theoretical maximum.

Previous studies concerning valine production in *C. glutamicum* have shown that inactivation of the PDHc resulted in significant improvement of valine production and high product yield (Blombach et al. [@CR9]; Blombach et al. [@CR8]). In our system, we also found that inactivation of the PDHc increases pyruvate availability; however, LDH becomes the more dominant enzyme, and lactic acid becomes the primary product, similar to our results in the ∆*pyc* strain. It seemed that by constructing a ∆*aceE*∆*ldh* strain, we may convert this "available" pyruvate to isobutanol. Initially, this double knockout strain produced isobutanol well in comparison with WT but productivity slowed drastically after the cells entered the stationary phase. We hypothesized that TCA cycle activity might be important for isobutanol production in *C. glutamicum*, as this metabolic pathway supplies ATP and NAD(P)H. More specifically, NADPH has been shown to be a critical cofactor for the production of amino acids in *C. glutamicum*, including lysine and valine (Kabus et al. [@CR21]; Marx et al. [@CR26]), and in fact, the introduction of a *pgi* knockout in a strain deficient in PDHc activity has been shown to increase the valine yield from glucose (Blombach et al. [@CR9]). Unfortunately, redirecting the carbon flow through the pentose phosphate pathway by disruption of PGI (∆*ldh*∆*aceE*∆*pgi*) eliminated isobutanol production and severely stunted glucose consumption. This is in contrast with results obtained for valine production (Blombach et al. [@CR9]); however, unlike the valine pathway that ultimately consumes 2 mole of NADPH per mole of valine produced, here, the isobutanol pathway consumes 1 mole of NADPH and 1 mole of NADH per mole of isobutanol produced. This difference in redox cofactor requirement may be one reason for the ineffectiveness of a *pgi* knockout on isobutanol production. Also, several studies have shown that PGI mutants dramatically disturb NADPH metabolism and retard growth and glucose consumption in *C. glutamicum* (Marx et al. [@CR26]).

Our initial attempts to produce isobutanol in *C. glutamicum* resulted in the maximum production of 4.9 g/L in a ∆*pyc*∆*ldh* background. This success emphasizes the efficacy of the 2-keto acid based pathways for higher alcohol production, and future studies should be aimed to increase the low isobutanol yield. There have been several cases of generating mutants of *C. glutamicum* that overproduce valine, as well as several other pertinent amino acids for higher alcohol production such as isoleucine and threonine, by applying random mutagenesis coupled with a selection for growth in the presence of an amino acid analogue (Shimura [@CR33], [@CR34]; Uemura et al. [@CR35]). In addition, other metabolic engineering tools and experiences (Barkovich and Liao [@CR37]; Liao and Delgado [@CR36]) might prove to be useful to help elucidate the effects of the mutations introduced and to direct the metabolic flux to the desirable pathway(s). Perhaps this would be an effective method to develop isobutanol overproducers as valine and isobutanol share the same 2-keto acid precursor, KIV. As a first attempt at isobutanol production in *C. glutamicum*, our primary challenge was the effective expression of heterologous enzymes (KDC and ALS) that are important for isobutanol production. The success we have had with this more-tolerant host supports future studies to engineer several higher chain alcohol production platforms in *C. glutamicum* using the 2-keto acid pathways.
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